Lymphoma
📧 Sign up to get email alerts when something new happens for Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2015-08-19Clinical Trial Update: Combination Chemotherapy Plus Interferon Alfa or Rituximab in Treating Patients With Stage III or Stage IV Lymphoma [Phase 2]
A Phase 2 trial evaluating combination chemotherapy plus either interferon alfa or rituximab for Stage III/IV lymphoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-06-16Clinical Trial Update: Single Dose of Intravenous rhTNF-α and Liposomal Doxorubicin in Patients With Advanced Solid Tumors or Lymphomas [Phase 1]
The Phase 1 trial evaluating a single dose of intravenous recombinant human TNF-α with liposomal doxorubicin in patients with advanced solid…
-
CLINICAL_TRIALS withdrawal · 2015-06-08Clinical Trial Update: Total Marrow and Total Lymph Node Irradiation, Fludarabine, and Melphalan Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Hematological Cancer That Has Not Responded to Treatment [Phase 1]
Phase 1 trial evaluating total marrow and total lymph node irradiation with fludarabine and melphalan followed by donor stem cell transplant…
-
CLINICAL_TRIALS withdrawal · 2015-05-29Clinical Trial Update: Perceptions of Burden in Patients With Late-Stage Cancer and Their Caregivers
A clinical trial evaluating perceived burden in late-stage cancer patients and their caregivers has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-03-06Clinical Trial Update: S0629, Observation or Combination Chemotherapy, Bortezomib, Thalidomide, and Rituximab Followed By Two Autologous Peripheral Blood Stem Cell Transplants in Treating Patients With Waldenstrom Macroglobulinemia [Phase 2]
A Phase 2 SWOG trial evaluating observation or combination chemotherapy with bortezomib, thalidomide, and rituximab followed by two autologo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2014-08-08Clinical Trial Update: Talotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to Treatment [Phase 1]
Phase 1 trial of talotrexin in children with recurrent solid tumors or leukemia was withdrawn before completion, with cases including brain/…
-
CLINICAL_TRIALS withdrawal · 2014-03-10Clinical Trial Update: Early Detection of Graft-Versus-Host Disease in Patients Undergoing a Donor Bone Marrow Transplant
A Mayo Clinic-sponsored trial evaluating early detection of graft-versus-host disease in lymphoma patients undergoing donor bone marrow tran…
-
CLINICAL_TRIALS withdrawal · 2013-04-02Clinical Trial Update: Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With Cancer [NA]
Clinical trial evaluating Aprepitant and Ondansetron for opioid-induced nausea and vomiting in cancer patients; the study was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-03-07Clinical Trial Update: Antiviral Therapy Plus Either Peripheral Stem Cell or Umbilical Cord Blood Transplantation in Treating Patients Who Are HIV Positive and Have Hematologic Cancer [Phase 1]
Phase 1 study evaluating antiviral therapy plus stem cell transplantation in HIV-positive patients with leukemia or lymphoma has been withdr…
-
CLINICAL_TRIALS withdrawal · 2013-02-15Clinical Trial Update: Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies [Phase 1, Phase 2]
Clinical trial update notes the withdrawal of a Phase 1/2 study evaluating antimicrobial versus saline solutions to maintain catheter patenc…
-
CLINICAL_TRIALS withdrawal · 2013-01-08Clinical Trial Update: Alemtuzumab in Treating Patients With Waldenstrom's Macroglobulinemia [Phase 2]
A Phase 2 clinical trial of alemtuzumab for Waldenström's macroglobulinemia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-12-06Clinical Trial Update: Combined CT Colonography and PET Imaging in Mantle Cell Lymphoma
A clinical trial evaluating combined CT colonography and PET imaging in Mantle cell lymphoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-11-21Clinical Trial Update: Imetelstat for Children With Refractory or Recurrent Solid Tumors and Lymphoma [Phase 1]
Phase 1 trial of imetelstat in children with refractory or recurrent solid tumors or lymphoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-11-08Clinical Trial Update: Bendamustine in Acute Lymphoblastic Leukemia/Lymphoma (ALL) [Phase 2]
A Phase 2 trial evaluating bendamustine for acute lymphoblastic leukemia and lymphoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-10-11Clinical Trial Update: Infusion of Expanded Cord Blood T Cells [Phase 1]
A Phase 1 clinical trial evaluating the infusion of expanded cord blood T cells for stem cell transplantation in leukemia has been withdrawn…
-
CLINICAL_TRIALS withdrawal · 2012-10-02Clinical Trial Update: Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 study of busulfan and fludarabine conditioning before donor stem cell transplant for hematologic cancers has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-08-02Clinical Trial Update: Comparing Fresh Random Platelets and Autologous Cryopreserved Thrombosol Treated Autologous Platelets [Phase 3]
This Phase 3 trial comparing fresh random platelets with autologous thrombosol-treated autologous platelets in patients with leukemia or lym…
-
CLINICAL_TRIALS withdrawal · 2012-07-31Clinical Trial Update: TTP607 in Refractory Solid Malignancies [Phase 1]
Phase 1 trial of TTP607 for advanced cancers and lymphoma was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-07-19Clinical Trial Update: Safety Study of Darinaparsin in Combination With Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) to Treat Lymphoma [Phase 1]
A Phase 1 safety study evaluating darinaparsin in combination with CHOP for lymphoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-06-20Clinical Trial Update: Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and Neutropenia [Phase 1]
A Phase 1 trial of recombinant human Mannose-Binding Lectin (MBL) in young patients with MBL deficiency and fever with neutropenia was withd…
-
CLINICAL_TRIALS withdrawal · 2012-02-24Clinical Trial Update: Molecular Epidemiology of Lymphoma Patients
This clinical trial update shows that the study on the molecular epidemiology of lymphoma patients has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-01-23Clinical Trial Update: Study of Forodesine Hydrochloride in Patients With Relapsed/Refractory Precursor T-Lymphoblastic Leukemia/Lymphoma Who Have Failed Two or More Prior Treatment Regimens [Phase 2]
A Phase 2 study of forodesine hydrochloride in relapsed/refractory precursor T-lymphoblastic leukemia/lymphoma was terminated; no efficacy r…
-
CLINICAL_TRIALS withdrawal · 2011-05-16Clinical Trial Update: Preliminary Anti-tumour Activity of mTor Kinase Inhibitor in Advanced Tumours [Phase 1]
The phase 1 trial of an mTOR kinase inhibitor in advanced solid tumors and lymphomas was withdrawn; no further results are reported.